<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:chebi fb="4" ids="30225">Positron</z:chebi> emission tomography (PET) studies in humans have used (11)C-<z:chebi fb="0" ids="5103">flumazenil</z:chebi> (FMZ) to assess neuronal viability after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we aimed to study whether (11)C-FMZ binding was sensitive to neuronal damage in the <z:hpo ids='HP_0011009'>acute</z:hpo> phase following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion in the rat brain </plain></SENT>
<SENT sid="2" pm="."><plain>EXPERIMENTAL PROCEDURES: Transient (2 h followed by reperfusion) and permanent intraluminal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was carried out </plain></SENT>
<SENT sid="3" pm="."><plain>(11)C-FMZ binding was studied by PET up to 24 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Tissue infarction was evaluated post-mortem at 24 h </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemistry against a neuronal nuclei specific protein (NeuN) was performed to assess neuronal injury </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: No decrease in (11)C-FMZ binding was detected in the ipsilateral cortex up to 24 h post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the model of transient occlusion despite the fact that rats developed cortical and striatal infarction, and neuronal injury was clearly apparent at this time </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, (11)C-FMZ binding was significantly depressed in the ipsilateral cortex at 24 h following permanent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: This finding evidences that (11)C-FMZ binding is not sensitive to neuronal damage on the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion in the rat brain </plain></SENT>
</text></document>